Argenica Therapeutics (ASX:AGN) Common Stock: A$29.66 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASX:AGN Argenica Therapeutics Ltd ASX:AGN
30 GF Score
Price A$0.15
! 1 Warning Sign
View Full Analysis

What is Argenica Therapeutics Common Stock?

Argenica Therapeutics ASX:AGN +3.57% 30 Common Stock is A$29.66 Mil as of Dec. 2025. GuruFocus rates ASX:AGN with a GF Score™ of 30/100. The stock has 1 warning sign investors should review.

Argenica Therapeutics's quarterly common stock increased from Dec. 2024 (A$29.15 Mil) to Jun. 2025 (A$29.63 Mil) and increased from Jun. 2025 (A$29.63 Mil) to Dec. 2025 (A$29.66 Mil).

Argenica Therapeutics's annual common stock increased from Jun. 2023 (A$16.62 Mil) to Jun. 2024 (A$28.43 Mil) and increased from Jun. 2024 (A$28.43 Mil) to Jun. 2025 (A$29.63 Mil).

Argenica Therapeutics Common Stock Historical Data

* Premium members only.

The historical data trend for Argenica Therapeutics's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Argenica Therapeutics Common Stock Chart

Argenica Therapeutics Annual Data
Trend Jun21 Jun22 Jun23 Jun24 Jun25
Common Stock
8.05 13.07 16.62 28.43 29.63

Argenica Therapeutics Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 16.92 28.43 29.15 29.63 29.66
ASX:AGN
30GF Score
Argenica Therapeutics Ltd ASX:AGN
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Argenica Therapeutics Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of A$29.66 Mil mean?
Argenica Therapeutics (ASX:AGN) has a Common Stock of A$29.66 Mil as of Dec. 2025. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Argenica Therapeutics and its competitors.
Is Argenica Therapeutics' Common Stock too high?
Argenica Therapeutics' current Common Stock is A$29.66 Mil. Overall, Argenica Therapeutics has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Argenica Therapeutics' Common Stock compare to VRTX and REGN?
Argenica Therapeutics' Common Stock of A$29.66 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Argenica Therapeutics and its competitors. Argenica Therapeutics's current Common Stock is A$29.66 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Argenica Therapeutics stock overvalued right now?
Argenica Therapeutics (ASX:AGN) has a current Common Stock of A$29.66 Mil. The current Common Stock is A$29.66 Mil. Argenica Therapeutics' overall GF Score™ is 30/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Argenica Therapeutics (ASX:AGN), the current Common Stock is A$29.66 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Argenica Therapeutics Business Description

Address 117 Broadway, Unit 4, Nedlands, WA, AUS, 6009
Argenica Therapeutics Ltd is engaged in the research and development of novel drug candidates. Its ARG007 drug improves outcomes in pre-clinical stroke models and its non-clinical studies to other indications and regulatory consultants.
30GF Score

Get the complete analysis for ASX:AGN

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.15
Price